Resultados de la búsqueda

Straburzynska-Migaj E, Senni M, Wachter R, Fonseca C, Witte KK, Mueller C, Lonn E, Butylin D, Noe A, Schwende H, Lawrence D, Suryawanshi B, Pascual-Figal D; of TRANSITION Investigators. Early Initiation of Sacubitril/Valsartan in Patients With Acute Heart Failure and Renal Dysfunction: An Analysis of the TRANSITION Study J Card Fail (2023) 30:425-43
Link to the full text in Repisalud

Morales-Cano D, Izquierdo-García JL, Barreira B, Esquivel-Ruiz S, Callejo M, Pandolfi R, Villa-Valverde P, Rodríguez I, Cogolludo A, Ruiz-Cabello J, Perez-Vizcaino F, Moreno L. Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model. Front Pharmacol (2023) 14:1021535
Link to the full text in Repisalud

Ruiz-Medrano J, Puertas M, Almazán-Alonso E, Fernández-Jiménez M, Flores-Moreno I, Antón CS, García-Pavía P, Ruiz-Moreno JM. OPHTHALMOLOGIC INVOLVEMENT IN PATIENTS WITH HEREDITARY TRANSTHYRETIN AMYLOIDOSIS. RETINA-J RET VIT DIS (2023) 43:49-56
Link to the full text in Repisalud

Dumitru AC, Koehler M. Recent advances in the application of atomic force microscopy to structural biology. J STRUCT BIOL (2023) 215:107963

Paz-García M, Povo-Retana A, Jaén RI, Prieto P, Peraza DA, Zaragoza C, Hernandez-Jimenez M, Pineiro D, Regadera J, García-Bermejo ML, Rodríguez-Serrano EM, Sánchez-García S, Moro MA, Lizasoaín I, Delgado C, Valenzuela C, Boscá L. Beneficial effect of TLR4 blockade by a specific aptamer antagonist after acute myocardial infarction. Biomed Pharmacother (2023) 158:114214
Link to the full text in Repisalud

González-Correa C, Moleón J, Miñano S, Robles-Vera I, Toral M, Martín-Morales N, O'Valle F, Sánchez M, Gómez-Guzmán M, Jiménez R, Romero M, Duarte J. Mineralocorticoid receptor blockade improved gut microbiota dysbiosis by reducing gut sympathetic tone in spontaneously hypertensive rats. Biomed Pharmacother (2023) 158
Link to the full text in Repisalud

Gonzalez-Del-Hoyo M, Mas-Llado C, Blaya-Peña L, Siquier-Padilla J, Peral V, Rossello X. The fragility index in randomized clinical trials supporting clinical practice guidelines for acute coronary syndrome: measuring robustness from a different perspective. Eur Heart J Acute Cardiovasc Care (2023) 12:386-390

Rossello X, Vranckx P. MULTi-vessel Immediate vs. STAged RevaScularization in Acute Myocardial Infarction: the MULTISTARS AMI trial. Eur Heart J Acute Cardiovasc Care (2023) 12:629-630

Rossello X, Rubini Gimenez M. he dapagliflozin in patients with myocardial infarction (DAPA-MI) trial in perspective. Eur Heart J Acute Cardiovasc Care (2023) 12:862-863.

Gentile L, Coelho T, Dispenzieri A, Conceição I, Waddington-Cruz M, Kristen A, Wixner J, Diemberger I, Gonzalez-Moreno J, Cariou E, Maurer MS, Planté-Bordeneuve V, Garcia-Pavia P, Tournev I, Gonzalez-Costello J, Duarte AG, Grogan M, Mazzeo A, Chapman D, Gupta P, Glass O, Amass L; THAOS investigators. A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS). Orphanet J Rare Dis (2023) 18:350.
Link to the full text in Repisalud